| Lycorine: A prospective natural lead for anticancer drug discovery M Roy, L Liang, X Xiao, P Feng, M Ye, J Liu Biomedicine & Pharmacotherapy 107, 615-624, 2018 | 160 | 2018 |
| Lycorine downregulates HMGB1 to inhibit autophagy and enhances bortezomib activity in multiple myeloma M Roy, L Liang, X Xiao, Y Peng, Y Luo, W Zhou, J Zhang, L Qiu, S Zhang, ... Theranostics 6 (12), 2209, 2016 | 93 | 2016 |
| The efficacy and safety of oxandrolone treatment for patients with severe burns: a systematic review and meta-analysis H Li, Y Guo, Z Yang, M Roy, Q Guo Burns 42 (4), 717-727, 2016 | 88 | 2016 |
| Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration FY Khusbu, X Zhou, M Roy, FZ Chen, Q Cao, HC Chen The international journal of biochemistry & cell biology 118, 105644, 2020 | 64 | 2020 |
| Tumor suppressor role of protein 4.1 B/DAL-1 Z Wang, J Zhang, M Ye, M Zhu, B Zhang, M Roy, J Liu, X An Cellular and molecular life sciences 71 (24), 4815-4830, 2014 | 39 | 2014 |
| Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1 L Liang, Y Peng, J Zhang, Y Zhang, M Roy, X Han, X Xiao, S Sun, H Liu, ... haematologica 104 (11), 2178-2187, 2019 | 37 | 2019 |
| A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein H Li, J Liu, X Xiao, S Sun, H Zhang, Y Zhang, W Zhou, B Zhang, M Roy, ... Molecular Therapy-Nucleic Acids 18, 727-738, 2019 | 33 | 2019 |
| Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77 Y Luo, M Roy, X Xiao, S Sun, L Liang, H Chen, Y Fu, Y Sun, M Zhu, M Ye, ... Tumor Biology 36 (4), 2937-2945, 2015 | 28 | 2015 |
| Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1 H Li, M Roy, L Liang, W Cao, B Hu, Y Li, X Xiao, H Wang, M Ye, S Sun, ... Oncogene, 1-11, 2022 | 24 | 2022 |
| Nonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitors M Roy, YH Luo, M Ye, J Liu BioMed research international 2013, 2013 | 21 | 2013 |
| The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma L Liang, Y He, H Wang, H Zhou, L Xiao, M Ye, Y Kuang, S Luo, Y Zuo, ... British Journal of Haematology, 2020 | 19 | 2020 |
| Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases J Zhang, Y Jiang, X Han, M Roy, W Liu, X Zhao, J Liu Future Oncology 15 (7), 763-776, 2019 | 19 | 2019 |
| Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway H Wang, Y Gong, L Liang, L Xiao, H Yi, M Ye, M Roy, J Xia, W Zhou, ... British Journal of Haematology, 2020 | 17 | 2020 |
| MicroRNA-based therapy: a new dimension in epilepsy treatment H Liu, M Roy, FF Tian International Journal of Neuroscience 123 (9), 617-622, 2013 | 15 | 2013 |
| ILP-2: A New Bane and Therapeutic Target for Human Cancers Z Zhang, S Xiang, R Cui, H Peng, R Mridul, M Xiang Frontiers in Oncology 12, 2022 | | 2022 |
| p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia Y Kuang, X Han, P Cao, D Xiong, Y Peng, Z Liu, Z Xu, L Liang, M Roy, ... Blood Cells, Molecules, and Diseases, 102477, 2020 | | 2020 |
| Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in M Roy, L Liang, X Xiao Theranostics, 6 (12), 2016 | | 2016 |
| Bin Zhang, Mridul Roy, Jing Liu & Xiuli An Z Wang | | |
Mao YeHunan University or Central South University or Wenzhou Medical College在 hnu.edu.cn 的电子邮件经过验证
